Authors:
Van Horssen, PJ
Preijers, FWMB
Van Oosterhout, YVJM
Eling, WMC
De Witte, T
Citation: Pj. Van Horssen et al., Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice model, LEUK LYMPH, 39(5-6), 2000, pp. 591-599
Authors:
Jerjis, S
Croockewit, S
Preijers, F
Schaap, N
De Witte, T
Citation: S. Jerjis et al., Impact of chemotherapy on the mobilisation, harvest and economic costs of autologous peripheral stem cell transplantation in patients with multiple myeloma, LEUK LYMPH, 37(5-6), 2000, pp. 551-560
Citation: T. De Witte, Stem cell transplantation for patients with myelodysplastic syndrome and secondary leukemias, INT J HEMAT, 72(2), 2000, pp. 151-156
Authors:
Cahn, JY
Labopin, M
Sierra, J
Blaise, D
Reiffers, J
Ferrant, A
Bergmann, L
Visani, G
Cornelissen, J
De Witte, T
Bosi, A
Frassoni, F
Gorin, NC
Citation: Jy. Cahn et al., No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission, BR J HAEM, 110(2), 2000, pp. 308-314
Authors:
Jerjis, S
Croockewit, S
Muus, P
Schaap, N
Preijers, F
De Witte, T
Citation: S. Jerjis et al., Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia, LEUK LYMPH, 36(1-2), 1999, pp. 33-43
Authors:
Schattenberg, A
Schaap, N
Van de Wiel-Van Kemenade, E
Bar, B
Preijers, F
Van der Maazen, R
Roovers, E
De Witte, T
Citation: A. Schattenberg et al., In relapsed patients after lymphocyte depleted bone marrow transplantationthe percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion, LEUK LYMPH, 32(3-4), 1999, pp. 317-325